Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

LOCAL SHIFTING OF BLOOD IN THE LOWER EXTREMITIES

LOCAL SHIFTING OF BLOOD IN THE LOWER EXTREMITIES Medical and surgical therapy for peripheral vascular disease is designed for the most part to increase the blood supply to the affected part. It is inevitable that an increased blood flow to a portion of an extremity is supported by either an increase in cardiac output or vasoconstriction in other areas. It must always be borne in mind, therefore, that the therapeutic agents and procedures that increase blood flow to one tissue component of an extremity may cause a simultaneous decrease in blood flow in another part of the extremity. The classical clinical example of this is in the treatment of intermittent claudication. It cannot be assumed that therapeutic agents and procedures that increase skin blood flow will benefit patients with intermittent claudication. Friedlander, Silbert, and Bierman1 called attention to this fact by demonstrating that in most instances changes in calf muscle temperature did not parallel changes in skin http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

LOCAL SHIFTING OF BLOOD IN THE LOWER EXTREMITIES

JAMA , Volume 149 (9) – Jun 28, 1952

Loading next page...
 
/lp/american-medical-association/local-shifting-of-blood-in-the-lower-extremities-8S2dZyciiK
Publisher
American Medical Association
Copyright
Copyright © 1952 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1952.02930260023007
Publisher site
See Article on Publisher Site

Abstract

Medical and surgical therapy for peripheral vascular disease is designed for the most part to increase the blood supply to the affected part. It is inevitable that an increased blood flow to a portion of an extremity is supported by either an increase in cardiac output or vasoconstriction in other areas. It must always be borne in mind, therefore, that the therapeutic agents and procedures that increase blood flow to one tissue component of an extremity may cause a simultaneous decrease in blood flow in another part of the extremity. The classical clinical example of this is in the treatment of intermittent claudication. It cannot be assumed that therapeutic agents and procedures that increase skin blood flow will benefit patients with intermittent claudication. Friedlander, Silbert, and Bierman1 called attention to this fact by demonstrating that in most instances changes in calf muscle temperature did not parallel changes in skin

Journal

JAMAAmerican Medical Association

Published: Jun 28, 1952

There are no references for this article.